Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Comment by Insightful1on Nov 08, 2021 4:56pm
110 Views
Post# 34102068

RE:RE:RE:RE:RE:Updates!?

RE:RE:RE:RE:RE:Updates!?Watched the video and I think you make a solid observation. Empower/Rexall are all in. In Canada once they are in a number of clinics and they have solid data that suggests this is a well recieved service other clinics/pharmacies will have to offer this service or loose customers. The more interesting observation is that McKesson owns Rexall and it is a bit of a Beta ship for testing what is attracting their customers, if these locations show a strong response then McKesson has the power to move this through their channel. That is a gamechanger.

I think now that Covid is starting to abait their is a lot of global demand for access to dermatologists and Empower has recognized this early on, let's hope this is just the start.

https://stockhouse.com/companies/bullboard?symbol=c.cbdt&postid=34094253

3:30 markis where they talk about MedX
<< Previous
Bullboard Posts
Next >>